Evidence map›Paper›PMID 28695084›Full record

ArticlePublic health action2017

Unfavourable outcomes among patients with MDR-TB on the standard 24-month regimen in Maharashtra, India.

S L Suryawanshi, H D Shewade, S B Nagaraja, S A Nair, M Parmar

Abstract read
In one paragraph

Article in Public health action, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Long-term follow-up of persons diagnosed with multidrug-resistant TB in Chennai, India, 2013-2020.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2024
    Article
  9. Article
  10. Advancing TB research using digitized programmatic data.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

S L SuryawanshiWorld Health Organization, Country Office for India, New Delhi, India.
H D ShewadeInternational Union Against Tuberculosis and Lung Disease, South-East Asia Office, New Delhi, India.
S B NagarajaDepartment of Community Medicine, Employees' State Insurance Corporation Medical College and Post Graduate Institute of Medical Sciences and Research, Bangalore, India.
S A NairWorld Health Organization, Country Office for India, New Delhi, India.
M ParmarWorld Health Organization, Country Office for India, New Delhi, India.

Funding

World Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

deathIndialoss to follow-upmultidrug-resistant tuberculosisoperational research

Identifiers

PMID28695084
PMCPMC5493092

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.